Table of Contents Author Guidelines Submit a Manuscript
Interdisciplinary Perspectives on Infectious Diseases
Volume 2009, Article ID 840452, 13 pages
http://dx.doi.org/10.1155/2009/840452
Review Article

Cryptococcus gattii: An Emerging Cause of Fungal Disease in North America

1Centre for the Study of Host Resistance, McGill University, Montreal, QC, Canada H3G 1A4
2Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada H3A 2B4
3Department of Human Genetics, McGill University, Montreal, QC, Canada H3A 1B1
4Department of Medicine, McGill University, Montreal, QC, Canada H3G 1A4

Received 11 November 2008; Accepted 18 January 2009

Academic Editor: Bettina Fries

Copyright © 2009 Ashwin Dixit et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. W. Warnock, “Mycology,” in Manual of Clinical Microbiology. Vol. 2, P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller, Eds., ASM Press, Washington, DC, USA, 2007. View at Google Scholar
  2. D. L. Hawksworth, “The magnitude of fungal diversity: the 1.5 million species estimate revisited,” Mycological Research, vol. 105, no. 12, pp. 1422–1432, 2001. View at Publisher · View at Google Scholar
  3. K. A. Marr, R. A. Carter, F. Crippa, A. Wald, and L. Corey, “Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients,” Clinical Infectious Diseases, vol. 34, no. 7, pp. 909–917, 2002. View at Publisher · View at Google Scholar
  4. S. Husain, B. D. Alexander, P. Munoz et al., “Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi,” Clinical Infectious Diseases, vol. 37, no. 2, pp. 221–229, 2003. View at Publisher · View at Google Scholar
  5. M. Chayakulkeeree and J. R. Perfect, “Cryptococcosis,” Infectious Disease Clinics of North America, vol. 20, no. 3, pp. 507–544, 2006. View at Publisher · View at Google Scholar
  6. T. Bicanic and T. S. Harrison, “Cryptococcal meningitis,” British Medical Bulletin, vol. 72, no. 1, pp. 99–118, 2004. View at Publisher · View at Google Scholar
  7. F. Sanfelice, “Sull'azione patogena dei blastomiceti,” Annali Istituto d'Igiene della Universitá di Roma, vol. 5, pp. 239–262, 1895. View at Google Scholar
  8. K. J. Kwon-Chung and J. E. Bennett, Medical Mycology, Lea and Febiger, Philadelphia, Pa, USA, 1992.
  9. L. Ajello, “Occurrence of Cryptococcus neoformans in soils,” The American Journal of Hygiene, vol. 67, no. 1, pp. 72–77, 1958. View at Google Scholar
  10. C. W. Emmons, “Isolation of Cryptococcus neoformans from soil,” The Journal of Bacteriology, vol. 62, no. 6, pp. 685–690, 1951. View at Google Scholar
  11. K. J. Kwon-Chung, “A new genus, Filobasidiella, the perfect state of Cryptococcus neoformans,” Mycologia, vol. 67, no. 6, pp. 1197–1200, 1975. View at Publisher · View at Google Scholar
  12. D. Ellis, “Mycology Online,” 2007, http://www.mycology.adelaide.edu.au.
  13. J. R. Perfect and A. Casadevall, “Cryptococcosis,” Infectious Disease Clinics of North America, vol. 16, no. 4, pp. 837–874, 2002. View at Publisher · View at Google Scholar
  14. R. Vanbreuseghem and M. Takashio, “An atypical strain of Cryptococcus neoformans (San Felice) Vuillemin 1894. II. Cryptococcus neoformans var. gattii var. nov,” Annales de la Societe Belge de Medecine Tropicale, vol. 50, no. 6, pp. 695–702, 1970. View at Google Scholar
  15. T. C. Sorrell, “Cryptococcus neoformans variety gattii,” Medical Mycology, vol. 39, no. 2, pp. 155–168, 2001. View at Publisher · View at Google Scholar
  16. K. J. Kwon-Chung and J. E. Bennett, “Epidemiologic differences between the two varieties of Cryptococcus neoformans,” American Journal of Epidemiology, vol. 120, no. 1, pp. 123–130, 1984. View at Google Scholar
  17. T. Boekhout, B. Theelen, M. Diaz et al., “Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans,” Microbiology, vol. 147, no. 4, pp. 891–907, 2001. View at Google Scholar
  18. B. Speed and D. Dunt, “Clinical and host differences between infections with the two varieties of Cryptococcus neoformans,” Clinical Infectious Diseases, vol. 21, no. 1, pp. 35–36, 1995. View at Google Scholar
  19. R. Rozenbaum and A. J. Gonçalves, “Clinical epidemiological study of 171 cases of cryptococcosis,” Clinical Infectious Diseases, vol. 18, no. 3, pp. 369–380, 1994. View at Google Scholar
  20. L. M. N. Hoang, J. A. Maguire, P. Doyle, M. Fyfe, and D. L. Roscoe, “Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997–2002): epidemiology, microbiology and histopathology,” Journal of Medical Microbiology, vol. 53, no. 9, pp. 935–940, 2004. View at Publisher · View at Google Scholar
  21. C. Berrie, “Outbreak of Cryptococcus gattii infection in humans in British Columbia,” Medscape Medical News, 2007.
  22. L. MacDougall, S. E. Kidd, E. Galanis et al., “Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA,” Emerging Infectious Diseases, vol. 13, no. 1, pp. 42–50, 2007. View at Google Scholar
  23. S. E. Kidd, F. Hagen, R. L. Tscharke et al., “A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada),” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 49, pp. 17258–17263, 2004. View at Publisher · View at Google Scholar
  24. A. Upton, J. A. Fraser, S. E. Kidd et al., “First contemporary case of human infection with Cryptococcus gattii in puget sound: evidence for spread of the Vancouver Island outbreak,” Journal of Clinical Microbiology, vol. 45, no. 9, pp. 3086–3088, 2007. View at Publisher · View at Google Scholar
  25. R. Levy, J. Pitout, P. Long, and M. J. Gill, “Late presentation of Cryptococcus gattii meningitis in a traveller to Vancouver Island: a case report,” The Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 18, no. 3, pp. 197–199, 2007. View at Google Scholar
  26. J. W. Fell, T. Boekhout, A. Fonseca, G. Scorzetti, and A. Statzell-Tallman, “Biodiversity and systematics of basidiomycetous yeasts as determined by large-subunit rDNA D1/D2 domain sequence analysis,” International Journal of Systematic and Evolutionary Microbiology, vol. 50, no. 3, pp. 1351–1371, 2000. View at Google Scholar
  27. G. Scorzetti, J. W. Fell, A. Fonseca, and A. Statzell-Tallman, “Systematics of basidiomycetous yeasts: a comparison of large subunit D1/D2 and internal transcribed spacer rDNA regions,” FEMS Yeast Research, vol. 2, no. 4, pp. 495–517, 2002. View at Publisher · View at Google Scholar
  28. C. Duncan, C. Stephen, and J. Campbell, “Clinical characteristics and predictors of mortality for Cryptococcus gattii infection in dogs and cats of southwestern British Columbia,” Canadian Veterinary Journal, vol. 47, no. 10, pp. 993–998, 2006. View at Google Scholar
  29. K. J. Kwon-Chung and A. Varma, “Do major species concepts support one, two or more species within Cryptococcus neoformans?” FEMS Yeast Research, vol. 6, no. 4, pp. 574–587, 2006. View at Publisher · View at Google Scholar
  30. E. E. Evans, “The antigenic composition of Cryptococcus neoformans. I. A serologic classification by means of the capsular and agglutination reactions,” The Journal of Immunology, vol. 64, no. 5, pp. 423–430, 1950. View at Google Scholar
  31. L. E. Yauch, J. S. Lam, and S. M. Levitz, “Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan,” PLoS Pathogens, vol. 2, no. 11, pp. 1060–1068, 2006. View at Publisher · View at Google Scholar
  32. D. E. Wilson, J. E. Bennett, and J. W. Bailey, “Serologic grouping of Cryptococcus neoformans,” Proceedings of the Society for Experimental Biology and Medicine, vol. 127, no. 3, pp. 820–823, 1968. View at Google Scholar
  33. K. B. Lengeler, G. M. Cox, and J. Heitman, “Serotype AD strains of Cryptococcus neoformans are diploid or aneuploid and are heterozygous at the mating-type locus,” Infection and Immunity, vol. 69, no. 1, pp. 115–122, 2001. View at Publisher · View at Google Scholar
  34. S. K. Mishra, F. Staib, U. Folkens, and R. A. Fromtling, “Serotypes of Cryptococcus neoformans strains isolated in Germany,” Journal of Clinical Microbiology, vol. 14, no. 1, pp. 106–107, 1981. View at Google Scholar
  35. M. Bovers, F. Hagen, E. E. Kuramae et al., “Unique hybrids between the fungal pathogens Cryptococcus neoformans and Cryptococcus gattii,” FEMS Yeast Research, vol. 6, no. 4, pp. 599–607, 2006. View at Publisher · View at Google Scholar
  36. M. Bovers, F. Hagen, E. E. Kuramae et al., “AIDS patient death caused by novel Cryptococcus neoformans × C. gattii hybrid,” Emerging Infectious Diseases, vol. 14, no. 7, pp. 1105–1108, 2008. View at Publisher · View at Google Scholar
  37. M. Rovers, F. Hagen, and T. Boekhout, “Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex,” Revista Iberoamericana de Micologia, vol. 25, no. 1, pp. S4–S12, 2008. View at Google Scholar
  38. K. J. Kwon-Chung, T. Boekhout, J. W. Fell, and M. Diaz, “Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae),” Taxon, vol. 51, no. 4, pp. 804–806, 2002. View at Publisher · View at Google Scholar
  39. J. Xu, R. Vilgalys, and T. G. Mitchell, “Multiple gene genealogies reveal recent dispersion and hybridization in the human pathogenic fungus Cryptococcus neoformans,” Molecular Ecology, vol. 9, no. 10, pp. 1471–1481, 2000. View at Publisher · View at Google Scholar
  40. K. J. Kwon-Chung, J. E. Bennett, and J. C. Rhodes, “Taxonomic studies on Filobasidiella species and their anamorphs,” Antonie van Leeuwenhoek, vol. 48, no. 1, pp. 25–38, 1982. View at Publisher · View at Google Scholar
  41. K. J. Kwon-Chung, “A new species of Filobasidiella, the sexual state of Cryptococcus neoformans B and C serotypes,” Mycologia, vol. 68, no. 4, pp. 943–946, 1976. View at Google Scholar
  42. W. Meyer, K. Marszewska, M. Amirmostofian et al., “Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA—a pilot study to standardize techniques on which to base a detailed epidemiological survey,” Electrophoresis, vol. 20, no. 8, pp. 1790–1799, 1999. View at Publisher · View at Google Scholar
  43. W. Meyer, T. G. Mitchell, E. Z. Freedman, and R. Vilgalys, “Hybridization probes for conventional DNA fingerprinting used as single primers in the polymerase chain reaction to distinguish strains of Cryptococcus neoformans,” Journal of Clinical Microbiology, vol. 31, no. 9, pp. 2274–2280, 1993. View at Google Scholar
  44. W. Meyer, A. Castañeda, S. Jackson et al., “Molecular typing of IberoAmerican Cryptococcus neoformans isolates,” Emerging Infectious Diseases, vol. 9, no. 2, pp. 189–195, 2003. View at Google Scholar
  45. M. Bovers, F. Hagen, E. E. Kuramae, and T. Boekhout, “Six monophyletic lineages identified within Cryptococcus neoformans and Cryptococcus gattii by multi-locus sequence typing,” Fungal Genetics and Biology, vol. 45, no. 4, pp. 400–421, 2008. View at Publisher · View at Google Scholar
  46. S. E. Kidd, H. Guo, K. H. Bartlett, J. Xu, and J. W. Kronstad, “Comparative gene genealogies indicate that two clonal lineages of Cryptococcus gattii in British Columbia resemble strains from other geographical areas,” Eukaryotic Cell, vol. 4, no. 10, pp. 1629–1638, 2005. View at Publisher · View at Google Scholar
  47. S. E. Kidd, Y. Chow, S. Mak et al., “Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest of the United States,” Applied and Environmental Microbiology, vol. 73, no. 5, pp. 1433–1443, 2007. View at Publisher · View at Google Scholar
  48. T. J. Pfeiffer and D. H. Ellis, “Environmental isolation of Cryptococcus neoformans var. gattii from Eucalyptus tereticornis,” Journal of Medical and Veterinary Mycology, vol. 30, no. 5, pp. 407–408, 1992. View at Publisher · View at Google Scholar
  49. D. H. Ellis and T. J. Pfeiffer, “Natural habitat of Cryptococcus neoformans var. gattii,” Journal of Clinical Microbiology, vol. 28, no. 7, pp. 1642–1644, 1990. View at Google Scholar
  50. S. E. Kidd, T. C. Sorrell, and W. Meyer, “Isolation of two molecular types of Cryptococcus neoformans var. gattii from insect frass,” Medical Mycology, vol. 41, no. 2, pp. 171–176, 2003. View at Publisher · View at Google Scholar
  51. E. Gezuele, L. Calegari, D. Sanabría, G. Davel, and E. Civila, “Isolation in uruguay of Cryptococcus neoformans var. gattii from nest of the wasp Polybia occidentalis,” Revista Iberoamericana de Micología, vol. 10, no. 1, pp. 5–6, 1993. View at Google Scholar
  52. J. P. van der Walt and D. B. Scott, “Bullera dendrophila sp. n,” Antonie van Leeuwenhoek, vol. 36, no. 1, pp. 383–387, 1970. View at Publisher · View at Google Scholar
  53. J. P. van der Walt, D. B. Scott, and W. C. van der Klift, “Six new Candida species from South African insect sources,” Mycopathologia et Mycologia Applicata, vol. 47, no. 3, pp. 221–236, 1972. View at Publisher · View at Google Scholar
  54. J. P. van der Walt, Y. Yamada, N. P. Ferreira, and P. D. G. Richards, “New basidiomycetous yeasts from Southern Africa. II. Sterigmatomyces wingfieldii sp. n,” Antonie van Leeuwenhoek, vol. 53, no. 3, pp. 137–142, 1987. View at Publisher · View at Google Scholar
  55. D. Ellis, D. Marriott, R. A. Hajjeh, D. Warnock, W. Meyer, and R. Barton, “Epidemiology: surveillance of fungal infections,” Medical Mycology, vol. 38, supplement 1, pp. 173–182, 2000. View at Google Scholar
  56. K. Tintelnot, K. Lemmer, H. Losert, G. Schär, and A. Polak, “Follow-up of epidemiological data of cryptococcosis in Austria, Germany and Switzerland with special focus on the characterization of clinical isolates,” Mycoses, vol. 47, no. 11-12, pp. 455–464, 2004. View at Publisher · View at Google Scholar
  57. M. Katsu, S. Kidd, A. Ando et al., “The internal transcribed spacers and 5.8S rRNA gene show extensive diversity among isolates of the Cryptococcus neoformans species complex,” FEMS Yeast Research, vol. 4, no. 4-5, pp. 377–388, 2004. View at Publisher · View at Google Scholar
  58. T. C. Sorrell, S. C. A. Chen, P. Ruma et al., “Concordance of clinical and environmental isolates of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting,” Journal of Clinical Microbiology, vol. 34, no. 5, pp. 1253–1260, 1996. View at Google Scholar
  59. M. A. Viviani, M. Cogliati, M. C. Esposto et al., “Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe,” FEMS Yeast Research, vol. 6, no. 4, pp. 614–619, 2006. View at Publisher · View at Google Scholar
  60. A. Jenney, K. Pandithage, D. A. Fisher, and B. J. Currie, “Cryptococcus infection in tropical Australia,” Journal of Clinical Microbiology, vol. 42, no. 8, pp. 3865–3868, 2004. View at Publisher · View at Google Scholar
  61. L. T. Campbell, B. J. Currie, M. Krockenberger et al., “Clonality and recombination in genetically differentiated subgroups of Cryptococcus gattii,” Eukaryotic Cell, vol. 4, no. 8, pp. 1403–1409, 2005. View at Publisher · View at Google Scholar
  62. S. C. A. Chen, B. J. Currie, H. M. Campbell et al., “Cryptococcus neoformans var. gattii infection in northern Australia: existence of an environmental source other than known host eucalypts,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 91, no. 5, pp. 547–550, 1997. View at Publisher · View at Google Scholar
  63. J. A. Fraser, S. S. Giles, E. C. Wenink et al., “Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak,” Nature, vol. 437, no. 7063, pp. 1360–1364, 2005. View at Publisher · View at Google Scholar
  64. P. Escandón, A. Sánchez, M. Martínez, W. Meyer, and E. Castañeda, “Molecular epidemiology of clinical and environmental isolates of the Cryptococcus neoformans species complex reveals a high genetic diversity and the presence of the molecular type VGII mating type a in Colombia,” FEMS Yeast Research, vol. 6, no. 4, pp. 625–635, 2006. View at Publisher · View at Google Scholar
  65. L. Trilles, M. D. S. Lazéra, B. Wanke et al., “Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil,” Memórias do Instituto Oswaldo Cruz, vol. 103, no. 5, pp. 455–462, 2008. View at Google Scholar
  66. J. A. Fraser, R. L. Subaran, C. B. Nichols, and J. Heitman, “Recapitulation of the sexual cycle of the primary fungal pathogen Cryptococcus neoformans var. gattii: implications for an outbreak on Vancouver Island, Canada,” Eukaryotic Cell, vol. 2, no. 5, pp. 1036–1045, 2003. View at Publisher · View at Google Scholar
  67. T. R. Kozel and R. P. Mastroianni, “Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis,” Infection and Immunity, vol. 14, no. 1, pp. 62–67, 1976. View at Google Scholar
  68. H. L. Collins and G. J. Bancroft, “Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses,” Infection and Immunity, vol. 59, no. 11, pp. 3883–3888, 1991. View at Google Scholar
  69. A. Vecchiarelli, C. Retini, D. Pietrella et al., “Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1ß secretion from human monocytes,” Infection and Immunity, vol. 63, no. 8, pp. 2919–2923, 1995. View at Google Scholar
  70. J. W. Murphy and J. W. Moorhead, “Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen,” The Journal of Immunology, vol. 128, no. 1, pp. 276–283, 1982. View at Google Scholar
  71. Z. M. Dong, L. Jackson, and J. W. Murphy, “Mechanisms for induction of L-selectin loss from T lymphocytes by a cryptococcal polysaccharide, glucuronoxylomannan,” Infection and Immunity, vol. 67, no. 1, pp. 220–229, 1999. View at Google Scholar
  72. Y. Wang and A. Casadevall, “Decreased susceptibility of melanized Cryptococcus neoformans to UV light,” Applied and Environmental Microbiology, vol. 60, no. 10, pp. 3864–3866, 1994. View at Google Scholar
  73. Y. Wang, P. Aisen, and A. Casadevall, “Cryptococcus neoformans melanin and virulence: mechanism of action,” Infection and Immunity, vol. 63, no. 8, pp. 3131–3136, 1995. View at Google Scholar
  74. E. S. Jacobson and H. S. Emery, “Catecholamine uptake, melanization, and oxygen toxicity in Cryptococcus neoformans,” Journal of Bacteriology, vol. 173, no. 1, pp. 401–403, 1991. View at Google Scholar
  75. J. D. Nosanchuk and A. Casadevall, “Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding,” Infection and Immunity, vol. 65, no. 5, pp. 1836–1841, 1997. View at Google Scholar
  76. G. M. Megson, D. A. Stevens, J. R. Hamilton, and D. W. Denning, “D-mannitol in cerebrospinal fluid of patients with AIDS and cryptococcal meningitis,” Journal of Clinical Microbiology, vol. 34, no. 1, pp. 218–221, 1996. View at Google Scholar
  77. A. Casadevall and J. R. Perfect, Cryptococcus neoformans, American Society for Microbiology Press, Washington, DC, USA, 1998.
  78. V. Chaturvedi, B. Wong, and S. L. Newman, “Oxidative killing of Cryptococcus neoformans by human neutrophils: evidence that fungal mannitol protects by scavenging reactive oxygen intermediates,” The Journal of Immunology, vol. 156, no. 10, pp. 3836–3840, 1996. View at Google Scholar
  79. L.-C. Chen, E. S. Blank, and A. Casadevall, “Extracellular proteinase activity of Cryptococcus neoformans,” Clinical and Diagnostic Laboratory Immunology, vol. 3, no. 5, pp. 570–574, 1996. View at Google Scholar
  80. C. H. Brueske, “Proteolytic activity of a clinical isolate of Cryptococcus neoformans,” Journal of Clinical Microbiology, vol. 23, no. 3, pp. 631–633, 1986. View at Google Scholar
  81. H. E. Müller and K. K. Sethi, “Proteolytic activity of Cryptococcus neoformans against human plasma proteins,” Medical Microbiology and Immunology, vol. 158, no. 2, pp. 129–134, 1972. View at Publisher · View at Google Scholar
  82. P. Ruma-Haynes, A. G. Brownlee, and T. C. Sorrell, “A rapid method for detecting extracellular proteinase activity in Cryptococcus neoformans and a survey of 63 isolates,” Journal of Medical Microbiology, vol. 49, no. 8, pp. 733–737, 2000. View at Google Scholar
  83. P. R. Williamson, “Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase,” Journal of Bacteriology, vol. 176, no. 3, pp. 656–664, 1994. View at Google Scholar
  84. C. E. Shaw and L. Kapica, “Production of diagnostic pigment by phenoloxidase activity of Cryptococcus neoformans,” Applied Microbiology, vol. 24, no. 5, pp. 824–830, 1972. View at Google Scholar
  85. S. D. Narasipura, V. Chaturvedi, and S. Chaturvedi, “Characterization of Cryptococcus neoformans variety gattii SOD2 reveals distinct roles of the two superoxide dismutases in fungal biology and virulence,” Molecular Microbiology, vol. 55, no. 6, pp. 1782–1800, 2005. View at Publisher · View at Google Scholar
  86. S. C. A. Chen, L. C. Wright, J. C. Golding, and T. C. Sorrell, “Purification and characterization of secretory phospholipase B, lysophospholipase and lysophospholipase/transacylase from a virulent strain of the pathogenic fungus Cryptococcus neoformans,” Biochemical Journal, vol. 347, no. 2, pp. 431–439, 2000. View at Publisher · View at Google Scholar
  87. G. M. Cox, J. Mukherjee, G. T. Cole, A. Casadevall, and J. R. Perfect, “Urease as a virulence factor in experimental cryptococcosis,” Infection and Immunity, vol. 68, no. 2, pp. 443–448, 2000. View at Publisher · View at Google Scholar
  88. M. A. Olszewski, M. C. Noverr, G.-H. Chen et al., “Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion,” The American Journal of Pathology, vol. 164, no. 5, pp. 1761–1771, 2004. View at Google Scholar
  89. B. L. Wickes, U. Edman, and J. C. Edman, “The Cryptococcus neoformans STE12α gene: a putative Saccharomyces cerevisiae STE12 homologue that is mating type specific,” Molecular Microbiology, vol. 26, no. 5, pp. 951–960, 1997. View at Publisher · View at Google Scholar
  90. C. L. Halliday, T. Bui, M. Krockenberger, R. Malik, D. H. Ellis, and D. A. Carter, “Presence of α and a mating types in environmental and clinical collections of Cryptococcus neoformans var. gattii strains from Australia,” Journal of Clinical Microbiology, vol. 37, no. 9, pp. 2920–2926, 1999. View at Google Scholar
  91. N. Jain, L. Li, D. C. McFadden et al., “Phenotypic switching in a Cryptococcus neoformans variety gattii strain is associated with changes in virulence and promotes dissemination to the central nervous system,” Infection and Immunity, vol. 74, no. 2, pp. 896–903, 2006. View at Publisher · View at Google Scholar
  92. P. M. Ellerbroek, A. M. E. Walenkamp, A. I. M. Hoepelman, and F. E. J. Coenjaerts, “Effects of the capsular polysaccharides of Cryptococcus neoformans on phagocyte migration and inflammatory mediators,” Current Medicinal Chemistry, vol. 11, no. 2, pp. 253–266, 2004. View at Publisher · View at Google Scholar
  93. Y. C. Chang, B. L. Wickes, G. F. Miller, L. A. Penoyer, and K. J. Kwon-Chung, “Cryptococcus neoformans STE12α regulates virulence but is not essential for mating,” Journal of Experimental Medicine, vol. 191, no. 5, pp. 871–882, 2000. View at Publisher · View at Google Scholar
  94. R. Cherniak and J. B. Sundstrom, “Polysaccharide antigens of the capsule of Cryptococcus neoformans,” Infection and Immunity, vol. 62, no. 5, pp. 1507–1512, 1994. View at Google Scholar
  95. P. Lupo, Y. C. Chang, B. L. Kelsall et al., “The presence of capsule in Cryptococcus neoformans influences the gene expression profile in dendritic cells during interaction with the fungus,” Infection and Immunity, vol. 76, no. 4, pp. 1581–1589, 2008. View at Publisher · View at Google Scholar
  96. B. J. Young and T. R. Kozel, “Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans,” Infection and Immunity, vol. 61, no. 7, pp. 2966–2972, 1993. View at Google Scholar
  97. D. H. Mitchell, T. C. Sorrell, A. M. Allworth et al., “Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome,” Clinical Infectious Diseases, vol. 20, no. 3, pp. 611–616, 1995. View at Google Scholar
  98. J. M. Torres-Rodríguez, E. Alvarado-Ramírez, and R. Gutiérrez-Gallego, “Urease activity in Cryptococcus neoformans and Cryptococcus gattii,” Revista Iberoamericana de Micologia, vol. 25, no. 1, pp. 27–31, 2008. View at Google Scholar
  99. O. W. Liu, C. D. Chun, E. D. Chow, C. Chen, H. D. Madhani, and S. M. Noble, “Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans,” Cell, vol. 135, no. 1, pp. 174–188, 2008. View at Publisher · View at Google Scholar
  100. D. L. Goldman, B. C. Fries, S. P. Franzot, L. Montella, and A. Casadevall, “Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14967–14972, 1998. View at Publisher · View at Google Scholar
  101. X. Lin, C. M. Hull, and J. Heitman, “Sexual reproduction between partners of the same mating type in Cryptococcus neoformans,” Nature, vol. 434, no. 7036, pp. 1017–1021, 2005. View at Publisher · View at Google Scholar
  102. C. M. Hull and J. Heitman, “Genetics of Cryptococcus neoformans,” Annual Review of Genetics, vol. 36, pp. 557–615, 2002. View at Publisher · View at Google Scholar
  103. J. Lindberg, F. Hagen, A. Laursen, J. Stenderup, and T. Boekhout, “Cryptococcus gattii risk for tourists visiting Vancouver Island, Canada,” Emerging Infectious Diseases, vol. 13, no. 1, pp. 178–179, 2007. View at Google Scholar
  104. A. Torda, R. K. Kumar, and P. D. Jones, “The pathology of human and murine pulmonary infection with Cryptococcus neoformans var. gattii,” Pathology, vol. 33, no. 4, pp. 475–478, 2001. View at Publisher · View at Google Scholar
  105. J. Capilla, C. M. L. Maffei, K. V. Clemons, R. A. Sobel, and D. A. Stevens, “Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice,” Medical Mycology, vol. 44, no. 7, pp. 601–610, 2006. View at Publisher · View at Google Scholar
  106. T. Boekhout, A. van Belkum, A. C. A. P. Leenders et al., “Molecular typing of Cryptococcus neoformans: taxonomic and epidemiological aspects,” International Journal of Systematic Bacteriology, vol. 47, no. 2, pp. 432–442, 1997. View at Google Scholar
  107. J. M. Torres-Rodríguez, Y. Morera, T. Baró, J. M. Corominas, and E. Castañeda, “Pathogenicity of Cryptococcus neoformans var. gattii in an immunocompetent mouse model,” Medical Mycology, vol. 41, no. 1, pp. 59–63, 2003. View at Publisher · View at Google Scholar
  108. J. M. Dora, S. Kelbert, C. Deutschendorf et al., “Cutaneous cryptococccosis due to Cryptococcus gattii in immunocompetent hosts: case report and review,” Mycopathologia, vol. 161, no. 4, pp. 235–238, 2006. View at Publisher · View at Google Scholar
  109. C. Duncan, H. Schwantje, C. Stephen, J. Campbell, and K. Bartlett, “Cryptococcus gattii in wildlife of Vancouver Island, British Columbia, Canada,” Journal of Wildlife Diseases, vol. 42, no. 1, pp. 175–178, 2006. View at Google Scholar
  110. C. Stephen, S. Lester, W. Black, M. Fyfe, and S. Raverty, “Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia,” The Canadian Veterinary Journal, vol. 43, no. 10, pp. 792–794, 2002. View at Google Scholar
  111. C. Duncan, C. Stephen, S. Lester, and K. H. Bartlett, “Sub-clinical infection and asymptomatic carriage of Cryptococcus gattii in dogs and cats during an outbreak of cryptococcosis,” Medical Mycology, vol. 43, no. 6, pp. 511–516, 2005. View at Publisher · View at Google Scholar
  112. T. F. Raso, K. Werther, E. T. Miranda, and M. J. S. Mendes-Giannini, “Cryptococcosis outbreak in psittacine birds in Brazil,” Medical Mycology, vol. 42, no. 4, pp. 355–362, 2004. View at Publisher · View at Google Scholar
  113. M. B. Krockenberger, P. J. Canfield, and R. Malik, “Cryptococcus neoformans var. gattii in the koala (Phascolarctos cinereus): a review of 43 cases of cryptococcosis,” Medical Mycology, vol. 41, no. 3, pp. 225–234, 2003. View at Publisher · View at Google Scholar
  114. G. J. Dewar and J. K. Kelly, “Cryptococcus gattii: an emerging cause of pulmonary nodules,” Canadian Respiratory Journal, vol. 15, no. 3, pp. 153–158, 2008. View at Google Scholar
  115. C. Duncan, C. Stephen, S. Lester, and K. H. Bartlett, “Follow-up study of dogs and cats with asymptomatic Cryptococcus gattii infection or nasal colonization,” Medical Mycology, vol. 43, no. 7, pp. 663–666, 2005. View at Publisher · View at Google Scholar
  116. C. Duncan, The emergence of Cryptococcus gattii in British Columbia: veterinary aspects, M.S. thesis, University of Saskatchewan, Saskatoon, Canada, 2005.
  117. J. D. Nosanchuk, S. Shoham, B. C. Fries, D. S. Shapiro, S. M. Levitz, and A. Casadevall, “Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient,” Annals of Internal Medicine, vol. 132, no. 3, pp. 205–208, 2000. View at Google Scholar
  118. K. Lagrou, J. van Eldere, S. Keuleers et al., “Zoonotic transmission of Cryptococcus neoformans from a magpie to an immunocompetent patient,” Journal of Internal Medicine, vol. 257, no. 4, pp. 385–388, 2005. View at Google Scholar
  119. C.-Y. Wang, H.-D. Wu, and P.-R. Hsueh, “Nosocomial transmission of cryptococcosis,” The New England Journal of Medicine, vol. 352, no. 12, pp. 1271–1272, 2005. View at Publisher · View at Google Scholar
  120. T. Baró, J. M. Torres-Rodríguez, M. H. De Mendoza, Y. Morera, and C. Alía, “First identification of autochthonous Cryptococcus neoformans var. gattii isolated from goats with predominantly severe pulmonary disease in Spain,” Journal of Clinical Microbiology, vol. 36, no. 2, pp. 458–461, 1998. View at Google Scholar
  121. S. E. Kidd, P. J. Bach, A. O. Hingston et al., “Cryptococcus gattii dispersal mechanisms, British Columbia, Canada,” Emerging Infectious Diseases, vol. 13, no. 1, pp. 51–57, 2007. View at Google Scholar
  122. A. Callejas, N. Ordoñez, M. C. Rodriguez, and E. Castañeda, “First isolation of Cryptococcus neoformans var. gattii, serotype C, from the environment in Colombia,” Medical Mycology, vol. 36, no. 5, pp. 341–344, 1998. View at Google Scholar
  123. L. MacDougall and M. Fyfe, “Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period,” Journal of Clinical Microbiology, vol. 44, no. 5, pp. 1851–1852, 2006. View at Publisher · View at Google Scholar
  124. F. Staib, M. Seibold, E. Antweiler, B. Fröhlich, S. Weber, and A. Blisse, “The brown colour effect (BCE) of Cryptococcus neoformans in the diagnosis, control and epidemiology of C. neoformans infections in AIDS patients,” Zentralblatt für Bakteriologie Mikrobiologie und Hygiene A, vol. 266, no. 1-2, pp. 167–177, 1987. View at Google Scholar
  125. K. J. Kwon-Chung, I. Polacheck, and J. E. Bennett, “Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (Serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C),” Journal of Clinical Microbiology, vol. 15, no. 3, pp. 535–537, 1982. View at Google Scholar
  126. M. S. Saag, R. J. Graybill, R. A. Larsen et al., “Practice guidelines for the management of cryptococcal disease,” Clinical Infectious Diseases, vol. 30, no. 4, pp. 710–718, 2000. View at Publisher · View at Google Scholar
  127. A. Gomez-Lopez, O. Zaragoza, M. Dos Anjos Martins, M. C. Melhem, J. L. Rodriguez-Tudela, and M. Cuenca-Estrella, “In vitro susceptibility of Cryptococcus gattii clinical isolates,” Clinical Microbiology and Infection, vol. 14, no. 7, pp. 727–730, 2008. View at Publisher · View at Google Scholar
  128. J. Morgan, K. M. McCarthy, S. Gould et al., “Cryptococcus gattii infection: characteristics and epidemiology of cases identified in a South African province with high HIV seroprevalence, 2002–2004,” Clinical Infectious Diseases, vol. 43, no. 8, pp. 1077–1080, 2006. View at Publisher · View at Google Scholar
  129. G. R. Thompson III, N. P. Wiederhold, A. W. Fothergill, A. C. Vallor, B. L. Wickes, and T. F. Patterson, “Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 1, pp. 309–311, 2009. View at Publisher · View at Google Scholar
  130. D. P. Granados and E. Castañeda, “Influence of climatic conditions on the isolation of members of the Cryptococcus neoformans species complex from trees in Colombia from 1992–2004,” FEMS Yeast Research, vol. 6, no. 4, pp. 636–644, 2006. View at Publisher · View at Google Scholar
  131. J. A. Fraser, S. M. Lim, S. Diezmann et al., “Yeast diversity sampling on the San Juan Islands reveals no evidence for the spread of the Vancouver Island Cryptococcus gattii outbreak to this locale,” FEMS Yeast Research, vol. 6, no. 4, pp. 620–624, 2006. View at Publisher · View at Google Scholar